Success >50 % faster build times than original EDC provider veeva.com From Early Adopter to Optimized Trials: Cara Therapeutics and Veeva Vault CDMS Clinical-stage biopharmaceutical company focused on the treatment of pruritus finds greater speed and flexibility in clinical trials with modern EDC 1 Success Highlights Greater CRF consistency and standardized trial data when working with CROs Rapid post-production changes with zero migrations Life as an Early Adopter Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing a novel class of peripherally acting kappa opioid agonist therapeutics with a primary focus for the treatment of pruritus and pain. The company’s fast paced environment meant it needed technology and processes

Join for free to read